Optimizing hepatitis B vaccination in prison

Perrodeau, F.; Pillot-Debelleix, M.; Vergniol, Julien; Lemonnier, François; Receveur, M.-C.; Trimoulet, P.; Raymond, I.; Port, G. Le; Gromb-Monnoyeur, S.

doi:10.1016/j.medmal.2016.01.002

Cited by 5 publications

(10 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The methods used to investigate the vaccination status of the inmates were: serological testing ( n = 10) [ 20 , 21 , 23 , 24 , 25 , 35 , 42 , 44 , 45 , 46 ], the use of questionnaires ( n = 5) [ 28 , 33 , 37 , 38 , 40 ], the combination of both ( n = 3) [ 26 , 31 , 36 ], the screening of institutional databases ( n = 5) [ 27 , 29 , 30 , 32 , 34 ], or directly by conducting a survey ( n = 5) [ 19 , 22 , 39 , 41 , 43 ].…”

Section: Resultsmentioning

confidence: 99%

“…The aim of the studies was to evaluate systematic vaccination or relevant update of the adult vaccination program ( n = 21) [ 19 , 21 , 22 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ], to explore the coverage of risk groups ( n = 7) [ 20 , 23 , 36 , 42 , 43 , 44 , 45 ], including in some studies vaccination status at the time of admission to prison ( n = 6) [ 20 , 24 , 35 , 37 , 43 , 46 ]. The risk groups studied were IDUs and hepatitis C positive (HCV) in the HBV studies [ 23 , 42 , 43 , 44 , 45 ], and men who have sex with men in a combined HAV/HBV immunization study [ 19 ] and in another HAV immunization study [ 20 ].…”

Section: Resultsmentioning

confidence: 99%

“…The risk groups studied were IDUs and hepatitis C positive (HCV) in the HBV studies [ 23 , 42 , 43 , 44 , 45 ], and men who have sex with men in a combined HAV/HBV immunization study [ 19 ] and in another HAV immunization study [ 20 ]. In 11 studies (39.2%), exclusively men were included [ 19 , 21 , 25 , 29 , 34 , 35 , 36 , 37 , 39 , 41 , 42 ], in 4 studies (14.2%) only women were included [ 22 , 24 , 28 , 38 ], in 11 articles (39.2%) both sexes [ 23 , 26 , 27 , 30 , 31 , 32 , 33 , 43 , 44 , 45 , 46 ] and in 2 (7.1%) these data were not recorded [ 20 , 40 ]. The most studied vaccination coverage was HBV ( n = 21) [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 42 , …”

Section: Resultsmentioning

confidence: 99%

“…Among the 21 studies that focused on HBV vaccine, five studies detailed the reasons why prisoners were not vaccinated [ 21 , 22 , 23 , 24 , 25 ]. As shown in Table 1 , most of the studies sought to update HBV vaccination programs to achieve improvements in vaccination coverage [ 21 , 22 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 ]. The vaccination schedules used were different, most commonly at 0 (entry point), 1 month, 2 months, and a booster between 6–12 months.…”

Section: Resultsmentioning

confidence: 99%

“…Regarding the type of interventions, accelerated HBV vaccination programs improved compliance and may contribute to achieve higher immunization rates, particularly for the high proportion of inmates serving short sentences [ 10 , 21 , 23 , 32 , 35 ]. In line with this finding, Palmateer et al described an association between a higher vaccination coverage in inmates who were imprisoned more than once [ 45 ].…”

Section: Discussionmentioning

confidence: 99%

See 4 more Smart Citations

Vaccination Coverage among Prisoners: A Systematic Review

Vicente-Alcalde¹,

Ruescas-Escolano

Harboe

et al. 2020

IJERPH

View full text Add to dashboard Cite

Prison inmates are highly susceptible for several infectious diseases, including vaccine-preventable diseases. We conducted a systematic international literature review on vaccination coverage against hepatitis B virus (HBV), hepatitis A virus (HAV), combined HAV/HBV, tetanus-diphtheria, influenza, pneumococcal, and combined measles, mumps, and rubella (MMR) in prison inmates, according to the PRISMA guidelines. The electronic databases were used Web of Science, MEDLINE, Scopus, and Cinhal. No language or time limit were applied to the search. We defined vaccination coverage as the proportion of vaccinated prisoners. There were no limitations in the search strategy regarding time period or language. Of 1079 identified studies, 28 studies were included in the review. In total, 21 reported on HBV vaccine coverage (range between 16–82%); three on HAV (range between 91–96%); two studies on combined HAV/HBV (77% in the second dose and 58% in the third); three studies on influenza vaccine (range between 36–46%), one of pneumococcal vaccine coverage (12%), and one on MMR coverage (74%). We found that data on vaccination coverage in prison inmates are scarce, heterogeneous, and do not include all relevant vaccines for this group. Current published literature indicate that prison inmates are under-immunized, particularly against HBV, influenza, MMR, and pneumococci. Strengthen immunization programs specifically for this population at risk and improvement of data record systems may contribute to better health care in prisoners.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Vaccination Coverage among Prisoners: A Systematic Review

Vicente-Alcalde¹,

Ruescas-Escolano

Harboe

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

Interventions to increase vaccine uptake among people who live and work in prisons: A global multistage scoping review

Moazen

Agbaria

Ismail

et al. 2023

Journal Community Psychology

View full text Add to dashboard Cite

The objective of this study is to examine interventions implemented to increase vaccine uptake among people who live and work in prisons around the world. Peer‐reviewed and gray literature databases were searched systematically to identify relevant information published from 2012 to 2022. Publications were evaluated by two researchers independently and underwent quality assessment through established tools. Of the 11,281 publications identified through peer‐reviewed (2607) and gray literature (8674) search, 17 met the inclusion criteria. In light of limited data, the identified interventions were categorized into two categories of educational and organizational interventions, and are discussed in the text. The lack of availability of vaccination services and interventions to increase vaccine uptake among people who live and work in prisons, worldwide, is a serious public health concern. These interventions reported in this review can be adapted and adopted to mitigate the burden of infectious diseases among people who live and work in prisons.

show abstract

Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries

Madeddu

Vroling²,

Oordt-Speets³

et al. 2019

Vaccine

View full text Add to dashboard Cite

Introduction: In 2016, more than 600,000 persons were being held in EU/EEA correctional facilities on a given day. People in prison may be at risk of vaccine-preventable diseases. While vaccination is effective also for people in prisone, little is known on coverage and implementation options. Methods: We performed a systematic review on existing evidence on vaccination in prison settings in the EU/EEA. We searched peer-reviewed and grey literature following international methodology and reporting standards, to gather records published between 1980 and 2016 in all languages. We analysed quantitative (uptake, acceptance, (cost-)effectiveness) and qualitative (barriers) outcomes. Results: Out of 7,041 identified records, 19 full-text articles were included from peer-reviewed literature and two from grey literature. Of these, 18 reported on hepatitis A and/or B virus (HAV/HBV), two on influenza and one on MMR vaccination. Two studies on HAV vaccine reported varying acceptance (5%-91%) and uptake rates (62.9%-70.5%). Seven studies reported on HBV vaccination. A comparative study showed a significantly higher uptake of the third HBV vaccine dose with the very rapid (63%) compared to the standard schedule (20%). HBV vaccination was generally well accepted (54%-100%), whereas uptake was variable (dose 1:23%-100%, dose 2:48%-92%, dose 3:19%-80%). One study on the combined HAV/HBV vaccine reported an acceptance rate of 34%, and declining uptake following dose 1. One study on influenza vaccine showed an uptake of 42%-46%, while another reported a MMR vaccine acceptance of 80% and an uptake of 74%. Overall, main reasons for non-vaccination included release from/or transfer between prisons, and refusal. Conclusions: This systematic review highlighted important knowledge gaps and operational challenges for vaccination in prison settings. Vaccination is an effective measure that warrants comprehensive and tailored implementation to reduce the preventable disease burden, avoid risks of large outbreaks of vaccine-preventable diseases, and contribute to health equity for people in prison.

show abstract

Optimizing hepatitis B vaccination in prison

Cited by 5 publications

References 3 publications

Vaccination Coverage among Prisoners: A Systematic Review

Vaccination Coverage among Prisoners: A Systematic Review

Interventions to increase vaccine uptake among people who live and work in prisons: A global multistage scoping review

Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries

Contact Info

Product

Resources

About